Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Preferred Pharmaceuticals, Inc. recalls Duloxetine Delayed-Release Cap USP 30mg

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Products
  • Duloxetine Delayed-Release Cap USP 30mg
Where it was sold

Product distributed to CA, FL, OK, KS and CT

States: California, Connecticut, Florida, Kansas, Oklahoma

Units affected
66 bottles of 30 tablets
About this recall
Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03